Erratum to: Infusion of donor lymphocytes expressing the herpes simplex virus thymidine kinase suicide gene for recurrent hematologic malignancies after allogeneic hematopoietic stem cell transplantation
Int J Hematol. 2015 Oct;102(4):506.
doi: 10.1007/s12185-015-1866-1.
1 Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
2 Division of Experimental Therapeutics, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
3 Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
4 Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
5 Center for Cell and Gene Therapy, Takara Bio Inc, Seta 3-4-1, Otsu, Shiga, 520-2193, Japan.
6 Division of Hematology and Oncology, St. Luke's International Hospital, 9-1 Akashi-cho, Chou-ku, Tokyo, 104-8560, Japan.
7 Research Planning and Management Department, St. Luke's International Hospital, 9-1 Akashi-cho, Chou-ku, Tokyo, 104-8560, Japan.
8 Immunotherapy and Cell Therapy Service, St. Luke's International University and Hospital, 9-1 Akashi-cho, Chou-ku, Tokyo, 104-8560, Japan. [email protected].